HEADER HYDROLASE 28-OCT-11 4A5S TITLE CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC TITLE 2 DPP4 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIPEPTIDYL PEPTIDASE 4 SOLUBLE FORM; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM, DIPEPTIDYL PEPTIDASE COMPND 5 4, ADABP, ADENOSINE DEAMINASE COMPLEXING PROTEIN 2, ADCP-2, COMPND 6 DIPEPTIDYL PEPTIDASE IV, DPP IV, T-CELL ACTIVATION ANTIGEN CD26, COMPND 7 TP103, CD_ANTIGEN=CD26; COMPND 8 EC: 3.4.14.5; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS HYDROLASE, TYPE 2 DIABETES, NOVARTIS COMPOUND NVP-BIV988 EXPDTA X-RAY DIFFRACTION AUTHOR N.OSTERMANN,M.KROEMER,F.ZINK,B.GERHARTZ,J.M.SUTTON,D.E.CLARK, AUTHOR 2 S.J.DUNSDON,G.FENTON,A.FILLMORE,N.V.HARRIS,C.HIGGS,C.A.HURLEY, AUTHOR 3 S.L.KRINTEL,R.E.MACKENZIE,A.DUTTAROY,E.GANGL,W.MANIARA,R.SEDRANI, AUTHOR 4 K.NAMOTO,F.SIROCKIN,J.TRAPPE,U.HASSIEPEN,D.K.BAESCHLIN REVDAT 2 29-JUL-20 4A5S 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 08-FEB-12 4A5S 0 JRNL AUTH J.M.SUTTON,D.E.CLARK,S.J.DUNSDON,G.FENTON,A.FILLMORE, JRNL AUTH 2 N.V.HARRIS,C.HIGGS,C.A.HURLEY,S.L.KRINTEL,R.E.MACKENZIE, JRNL AUTH 3 A.DUTTAROY,E.GANGL,W.MANIARA,R.SEDRANI,K.NAMOTO,N.OSTERMANN, JRNL AUTH 4 B.GERHARTZ,F.SIROCKIN,J.TRAPPE,U.HASSIEPEN,D.K.BAESCHLIN JRNL TITL NOVEL HETEROCYCLIC DPP-4 INHIBITORS FOR THE TREATMENT OF JRNL TITL 2 TYPE 2 DIABETES. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 1464 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22177783 JRNL DOI 10.1016/J.BMCL.2011.11.054 REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 284274 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.800 REMARK 3 FREE R VALUE TEST SET COUNT : 5116 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.74 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 20777 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1925 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 20403 REMARK 3 BIN R VALUE (WORKING SET) : 0.1924 REMARK 3 BIN FREE R VALUE : 0.1959 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 374 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 11961 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 333 REMARK 3 SOLVENT ATOMS : 1590 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15340 REMARK 3 B22 (A**2) : 0.23280 REMARK 3 B33 (A**2) : -0.07940 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.155 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.068 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.066 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.066 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.064 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 12792 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 17481 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 4368 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 311 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1868 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 12792 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1677 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 16099 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.30 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.91 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY. REMARK 4 REMARK 4 4A5S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1290050100. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00054 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 284276 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620 REMARK 200 RESOLUTION RANGE LOW (A) : 87.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.890 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.09 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 UL PROTEIN, 0.4 UL RESERVOIR, 0.25 REMARK 280 UL WATER; PROTEIN SOLUTION: 5.2 MG/ML DPP4, 25 MM TRIS PH 8, 25 REMARK 280 MM NACL, 2 MM NVP-BIV988-AA-1, 2% DMSO; RESERVOIR SOLUTION: 40% REMARK 280 PEG 1000, 200 MM TRIS PH 9.0, 200 MM AMMONIUM SULFATE, 5% REMARK 280 GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 48.59150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 95.34950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 60.71200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 95.34950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.59150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 60.71200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 60290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 39 REMARK 465 ALA A 768 REMARK 465 ALA A 769 REMARK 465 SER A 770 REMARK 465 TRP A 771 REMARK 465 SER A 772 REMARK 465 HIS A 773 REMARK 465 PRO A 774 REMARK 465 GLN A 775 REMARK 465 PHE A 776 REMARK 465 GLU A 777 REMARK 465 LYS A 778 REMARK 465 SER B 39 REMARK 465 PRO B 774 REMARK 465 GLN B 775 REMARK 465 PHE B 776 REMARK 465 GLU B 777 REMARK 465 LYS B 778 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 767 CA C O CB REMARK 470 HIS B 773 CA C O CB CG ND1 CD2 REMARK 470 HIS B 773 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 74 -5.68 64.71 REMARK 500 GLN A 123 -101.46 -111.60 REMARK 500 TRP A 124 -144.44 -95.83 REMARK 500 HIS A 162 35.67 -151.42 REMARK 500 ILE A 193 -56.78 -128.05 REMARK 500 ILE A 193 -61.20 -125.25 REMARK 500 SER A 242 -165.31 64.32 REMARK 500 GLN A 320 37.64 -74.86 REMARK 500 LYS A 423 16.17 59.41 REMARK 500 ASN A 450 70.55 -151.64 REMARK 500 ASN A 487 26.78 -140.40 REMARK 500 TYR A 547 -75.68 -117.44 REMARK 500 ARG A 597 47.54 -143.09 REMARK 500 THR A 600 -96.58 -119.12 REMARK 500 SER A 630 -124.30 64.27 REMARK 500 ASP A 678 -101.30 -109.35 REMARK 500 ASN A 710 -66.54 -101.77 REMARK 500 ASP A 739 -159.43 -102.43 REMARK 500 ILE A 742 52.99 38.76 REMARK 500 ASN B 74 -0.85 66.78 REMARK 500 GLN B 123 -99.05 -110.60 REMARK 500 TRP B 124 -143.42 -97.47 REMARK 500 HIS B 162 32.97 -152.17 REMARK 500 ILE B 193 -60.23 -130.22 REMARK 500 SER B 242 -163.63 62.43 REMARK 500 GLN B 320 38.28 -77.11 REMARK 500 LYS B 423 16.35 57.11 REMARK 500 ASN B 450 77.22 -159.86 REMARK 500 TYR B 547 -76.25 -118.57 REMARK 500 ARG B 597 50.01 -141.66 REMARK 500 THR B 600 -95.35 -119.74 REMARK 500 SER B 630 -121.54 64.36 REMARK 500 ASP B 678 -95.92 -109.20 REMARK 500 ASN B 710 -69.79 -98.95 REMARK 500 ASP B 739 -156.61 -104.18 REMARK 500 ILE B 742 52.83 38.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1W1I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN REMARK 900 COMPLEX WITH ADENOSINE DEAMINASE REMARK 900 RELATED ID: 1RWQ RELATED DB: PDB REMARK 900 HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 5- AMINOMETHYL-6-(2,4- REMARK 900 DICHLORO-PHENYL)-2-(3,5-DIMETHOXY -PHENYL)-PYRIMIDIN-4-YLAMINE REMARK 900 RELATED ID: 1TK3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/ CD26 REMARK 900 RELATED ID: 2BGR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND REMARK 900 TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) REMARK 900 RELATED ID: 1N1M RELATED DB: PDB REMARK 900 HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH ANINHIBITOR REMARK 900 RELATED ID: 2G5T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV ( DPPIV) REMARK 900 COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 21AG REMARK 900 RELATED ID: 1NU6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP -IV) REMARK 900 RELATED ID: 1PFQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV /CD26 REMARK 900 RELATED ID: 1TKR RELATED DB: PDB REMARK 900 HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITHDIISOPROPYL REMARK 900 FLUOROPHOSPHATE REMARK 900 RELATED ID: 2G5P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV ( DPPIV) REMARK 900 COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 21AC REMARK 900 RELATED ID: 1X70 RELATED DB: PDB REMARK 900 HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINOACID REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1WCY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV ( DPPIV)COMPLEX REMARK 900 WITH DIPROTIN A REMARK 900 RELATED ID: 1R9M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV AT 2.1ANG. REMARK 900 RESOLUTION. REMARK 900 RELATED ID: 1NU8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP -IV)IN REMARK 900 COMPLEX WITH DIPROTIN A (ILI) REMARK 900 RELATED ID: 1J2E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV REMARK 900 RELATED ID: 2JID RELATED DB: PDB REMARK 900 HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 1-(3,4 -DIMETHOXY- REMARK 900 PHENYL)-3-M-TOLYL-PIPERIDINE-4-YLAMINE REMARK 900 RELATED ID: 1U8E RELATED DB: PDB REMARK 900 HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F REMARK 900 RELATED ID: 2G63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV ( DPPIV) REMARK 900 COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 24B REMARK 900 RELATED ID: 2BUB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPDIDASE IV (CD26 ) IN REMARK 900 COMPLEX WITH A REVERSED AMIDE INHIBITOR REMARK 900 RELATED ID: 2AJL RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF NOVEL BIARYL-BASED DIPEPTIDYL PEPTIDASEIV REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2BGN RELATED DB: PDB REMARK 900 HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2 -TAT(1-9) REMARK 900 BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) REMARK 900 RELATED ID: 1R9N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV INCOMPLEX WITH A REMARK 900 DECAPEPTIDE (TNPY) AT 2.3 ANG. RESOLUTION REMARK 999 REMARK 999 SEQUENCE REMARK 999 S437I SEQUENCE CONFLICT KNOWN IN UNIPROT. DBREF 4A5S A 39 766 UNP P27487 DPP4_HUMAN 39 766 DBREF 4A5S B 39 766 UNP P27487 DPP4_HUMAN 39 766 SEQADV 4A5S ALA A 767 UNP P27487 EXPRESSION TAG SEQADV 4A5S ALA A 768 UNP P27487 EXPRESSION TAG SEQADV 4A5S ALA A 769 UNP P27487 EXPRESSION TAG SEQADV 4A5S SER A 770 UNP P27487 EXPRESSION TAG SEQADV 4A5S TRP A 771 UNP P27487 EXPRESSION TAG SEQADV 4A5S SER A 772 UNP P27487 EXPRESSION TAG SEQADV 4A5S HIS A 773 UNP P27487 EXPRESSION TAG SEQADV 4A5S PRO A 774 UNP P27487 EXPRESSION TAG SEQADV 4A5S GLN A 775 UNP P27487 EXPRESSION TAG SEQADV 4A5S PHE A 776 UNP P27487 EXPRESSION TAG SEQADV 4A5S GLU A 777 UNP P27487 EXPRESSION TAG SEQADV 4A5S LYS A 778 UNP P27487 EXPRESSION TAG SEQADV 4A5S ILE A 437 UNP P27487 SER 437 CONFLICT SEQADV 4A5S ALA B 767 UNP P27487 EXPRESSION TAG SEQADV 4A5S ALA B 768 UNP P27487 EXPRESSION TAG SEQADV 4A5S ALA B 769 UNP P27487 EXPRESSION TAG SEQADV 4A5S SER B 770 UNP P27487 EXPRESSION TAG SEQADV 4A5S TRP B 771 UNP P27487 EXPRESSION TAG SEQADV 4A5S SER B 772 UNP P27487 EXPRESSION TAG SEQADV 4A5S HIS B 773 UNP P27487 EXPRESSION TAG SEQADV 4A5S PRO B 774 UNP P27487 EXPRESSION TAG SEQADV 4A5S GLN B 775 UNP P27487 EXPRESSION TAG SEQADV 4A5S PHE B 776 UNP P27487 EXPRESSION TAG SEQADV 4A5S GLU B 777 UNP P27487 EXPRESSION TAG SEQADV 4A5S LYS B 778 UNP P27487 EXPRESSION TAG SEQADV 4A5S ILE B 437 UNP P27487 SER 437 CONFLICT SEQRES 1 A 740 SER ARG LYS THR TYR THR LEU THR ASP TYR LEU LYS ASN SEQRES 2 A 740 THR TYR ARG LEU LYS LEU TYR SER LEU ARG TRP ILE SER SEQRES 3 A 740 ASP HIS GLU TYR LEU TYR LYS GLN GLU ASN ASN ILE LEU SEQRES 4 A 740 VAL PHE ASN ALA GLU TYR GLY ASN SER SER VAL PHE LEU SEQRES 5 A 740 GLU ASN SER THR PHE ASP GLU PHE GLY HIS SER ILE ASN SEQRES 6 A 740 ASP TYR SER ILE SER PRO ASP GLY GLN PHE ILE LEU LEU SEQRES 7 A 740 GLU TYR ASN TYR VAL LYS GLN TRP ARG HIS SER TYR THR SEQRES 8 A 740 ALA SER TYR ASP ILE TYR ASP LEU ASN LYS ARG GLN LEU SEQRES 9 A 740 ILE THR GLU GLU ARG ILE PRO ASN ASN THR GLN TRP VAL SEQRES 10 A 740 THR TRP SER PRO VAL GLY HIS LYS LEU ALA TYR VAL TRP SEQRES 11 A 740 ASN ASN ASP ILE TYR VAL LYS ILE GLU PRO ASN LEU PRO SEQRES 12 A 740 SER TYR ARG ILE THR TRP THR GLY LYS GLU ASP ILE ILE SEQRES 13 A 740 TYR ASN GLY ILE THR ASP TRP VAL TYR GLU GLU GLU VAL SEQRES 14 A 740 PHE SER ALA TYR SER ALA LEU TRP TRP SER PRO ASN GLY SEQRES 15 A 740 THR PHE LEU ALA TYR ALA GLN PHE ASN ASP THR GLU VAL SEQRES 16 A 740 PRO LEU ILE GLU TYR SER PHE TYR SER ASP GLU SER LEU SEQRES 17 A 740 GLN TYR PRO LYS THR VAL ARG VAL PRO TYR PRO LYS ALA SEQRES 18 A 740 GLY ALA VAL ASN PRO THR VAL LYS PHE PHE VAL VAL ASN SEQRES 19 A 740 THR ASP SER LEU SER SER VAL THR ASN ALA THR SER ILE SEQRES 20 A 740 GLN ILE THR ALA PRO ALA SER MET LEU ILE GLY ASP HIS SEQRES 21 A 740 TYR LEU CYS ASP VAL THR TRP ALA THR GLN GLU ARG ILE SEQRES 22 A 740 SER LEU GLN TRP LEU ARG ARG ILE GLN ASN TYR SER VAL SEQRES 23 A 740 MET ASP ILE CYS ASP TYR ASP GLU SER SER GLY ARG TRP SEQRES 24 A 740 ASN CYS LEU VAL ALA ARG GLN HIS ILE GLU MET SER THR SEQRES 25 A 740 THR GLY TRP VAL GLY ARG PHE ARG PRO SER GLU PRO HIS SEQRES 26 A 740 PHE THR LEU ASP GLY ASN SER PHE TYR LYS ILE ILE SER SEQRES 27 A 740 ASN GLU GLU GLY TYR ARG HIS ILE CYS TYR PHE GLN ILE SEQRES 28 A 740 ASP LYS LYS ASP CYS THR PHE ILE THR LYS GLY THR TRP SEQRES 29 A 740 GLU VAL ILE GLY ILE GLU ALA LEU THR SER ASP TYR LEU SEQRES 30 A 740 TYR TYR ILE SER ASN GLU TYR LYS GLY MET PRO GLY GLY SEQRES 31 A 740 ARG ASN LEU TYR LYS ILE GLN LEU ILE ASP TYR THR LYS SEQRES 32 A 740 VAL THR CYS LEU SER CYS GLU LEU ASN PRO GLU ARG CYS SEQRES 33 A 740 GLN TYR TYR SER VAL SER PHE SER LYS GLU ALA LYS TYR SEQRES 34 A 740 TYR GLN LEU ARG CYS SER GLY PRO GLY LEU PRO LEU TYR SEQRES 35 A 740 THR LEU HIS SER SER VAL ASN ASP LYS GLY LEU ARG VAL SEQRES 36 A 740 LEU GLU ASP ASN SER ALA LEU ASP LYS MET LEU GLN ASN SEQRES 37 A 740 VAL GLN MET PRO SER LYS LYS LEU ASP PHE ILE ILE LEU SEQRES 38 A 740 ASN GLU THR LYS PHE TRP TYR GLN MET ILE LEU PRO PRO SEQRES 39 A 740 HIS PHE ASP LYS SER LYS LYS TYR PRO LEU LEU LEU ASP SEQRES 40 A 740 VAL TYR ALA GLY PRO CYS SER GLN LYS ALA ASP THR VAL SEQRES 41 A 740 PHE ARG LEU ASN TRP ALA THR TYR LEU ALA SER THR GLU SEQRES 42 A 740 ASN ILE ILE VAL ALA SER PHE ASP GLY ARG GLY SER GLY SEQRES 43 A 740 TYR GLN GLY ASP LYS ILE MET HIS ALA ILE ASN ARG ARG SEQRES 44 A 740 LEU GLY THR PHE GLU VAL GLU ASP GLN ILE GLU ALA ALA SEQRES 45 A 740 ARG GLN PHE SER LYS MET GLY PHE VAL ASP ASN LYS ARG SEQRES 46 A 740 ILE ALA ILE TRP GLY TRP SER TYR GLY GLY TYR VAL THR SEQRES 47 A 740 SER MET VAL LEU GLY SER GLY SER GLY VAL PHE LYS CYS SEQRES 48 A 740 GLY ILE ALA VAL ALA PRO VAL SER ARG TRP GLU TYR TYR SEQRES 49 A 740 ASP SER VAL TYR THR GLU ARG TYR MET GLY LEU PRO THR SEQRES 50 A 740 PRO GLU ASP ASN LEU ASP HIS TYR ARG ASN SER THR VAL SEQRES 51 A 740 MET SER ARG ALA GLU ASN PHE LYS GLN VAL GLU TYR LEU SEQRES 52 A 740 LEU ILE HIS GLY THR ALA ASP ASP ASN VAL HIS PHE GLN SEQRES 53 A 740 GLN SER ALA GLN ILE SER LYS ALA LEU VAL ASP VAL GLY SEQRES 54 A 740 VAL ASP PHE GLN ALA MET TRP TYR THR ASP GLU ASP HIS SEQRES 55 A 740 GLY ILE ALA SER SER THR ALA HIS GLN HIS ILE TYR THR SEQRES 56 A 740 HIS MET SER HIS PHE ILE LYS GLN CYS PHE SER LEU PRO SEQRES 57 A 740 ALA ALA ALA SER TRP SER HIS PRO GLN PHE GLU LYS SEQRES 1 B 740 SER ARG LYS THR TYR THR LEU THR ASP TYR LEU LYS ASN SEQRES 2 B 740 THR TYR ARG LEU LYS LEU TYR SER LEU ARG TRP ILE SER SEQRES 3 B 740 ASP HIS GLU TYR LEU TYR LYS GLN GLU ASN ASN ILE LEU SEQRES 4 B 740 VAL PHE ASN ALA GLU TYR GLY ASN SER SER VAL PHE LEU SEQRES 5 B 740 GLU ASN SER THR PHE ASP GLU PHE GLY HIS SER ILE ASN SEQRES 6 B 740 ASP TYR SER ILE SER PRO ASP GLY GLN PHE ILE LEU LEU SEQRES 7 B 740 GLU TYR ASN TYR VAL LYS GLN TRP ARG HIS SER TYR THR SEQRES 8 B 740 ALA SER TYR ASP ILE TYR ASP LEU ASN LYS ARG GLN LEU SEQRES 9 B 740 ILE THR GLU GLU ARG ILE PRO ASN ASN THR GLN TRP VAL SEQRES 10 B 740 THR TRP SER PRO VAL GLY HIS LYS LEU ALA TYR VAL TRP SEQRES 11 B 740 ASN ASN ASP ILE TYR VAL LYS ILE GLU PRO ASN LEU PRO SEQRES 12 B 740 SER TYR ARG ILE THR TRP THR GLY LYS GLU ASP ILE ILE SEQRES 13 B 740 TYR ASN GLY ILE THR ASP TRP VAL TYR GLU GLU GLU VAL SEQRES 14 B 740 PHE SER ALA TYR SER ALA LEU TRP TRP SER PRO ASN GLY SEQRES 15 B 740 THR PHE LEU ALA TYR ALA GLN PHE ASN ASP THR GLU VAL SEQRES 16 B 740 PRO LEU ILE GLU TYR SER PHE TYR SER ASP GLU SER LEU SEQRES 17 B 740 GLN TYR PRO LYS THR VAL ARG VAL PRO TYR PRO LYS ALA SEQRES 18 B 740 GLY ALA VAL ASN PRO THR VAL LYS PHE PHE VAL VAL ASN SEQRES 19 B 740 THR ASP SER LEU SER SER VAL THR ASN ALA THR SER ILE SEQRES 20 B 740 GLN ILE THR ALA PRO ALA SER MET LEU ILE GLY ASP HIS SEQRES 21 B 740 TYR LEU CYS ASP VAL THR TRP ALA THR GLN GLU ARG ILE SEQRES 22 B 740 SER LEU GLN TRP LEU ARG ARG ILE GLN ASN TYR SER VAL SEQRES 23 B 740 MET ASP ILE CYS ASP TYR ASP GLU SER SER GLY ARG TRP SEQRES 24 B 740 ASN CYS LEU VAL ALA ARG GLN HIS ILE GLU MET SER THR SEQRES 25 B 740 THR GLY TRP VAL GLY ARG PHE ARG PRO SER GLU PRO HIS SEQRES 26 B 740 PHE THR LEU ASP GLY ASN SER PHE TYR LYS ILE ILE SER SEQRES 27 B 740 ASN GLU GLU GLY TYR ARG HIS ILE CYS TYR PHE GLN ILE SEQRES 28 B 740 ASP LYS LYS ASP CYS THR PHE ILE THR LYS GLY THR TRP SEQRES 29 B 740 GLU VAL ILE GLY ILE GLU ALA LEU THR SER ASP TYR LEU SEQRES 30 B 740 TYR TYR ILE SER ASN GLU TYR LYS GLY MET PRO GLY GLY SEQRES 31 B 740 ARG ASN LEU TYR LYS ILE GLN LEU ILE ASP TYR THR LYS SEQRES 32 B 740 VAL THR CYS LEU SER CYS GLU LEU ASN PRO GLU ARG CYS SEQRES 33 B 740 GLN TYR TYR SER VAL SER PHE SER LYS GLU ALA LYS TYR SEQRES 34 B 740 TYR GLN LEU ARG CYS SER GLY PRO GLY LEU PRO LEU TYR SEQRES 35 B 740 THR LEU HIS SER SER VAL ASN ASP LYS GLY LEU ARG VAL SEQRES 36 B 740 LEU GLU ASP ASN SER ALA LEU ASP LYS MET LEU GLN ASN SEQRES 37 B 740 VAL GLN MET PRO SER LYS LYS LEU ASP PHE ILE ILE LEU SEQRES 38 B 740 ASN GLU THR LYS PHE TRP TYR GLN MET ILE LEU PRO PRO SEQRES 39 B 740 HIS PHE ASP LYS SER LYS LYS TYR PRO LEU LEU LEU ASP SEQRES 40 B 740 VAL TYR ALA GLY PRO CYS SER GLN LYS ALA ASP THR VAL SEQRES 41 B 740 PHE ARG LEU ASN TRP ALA THR TYR LEU ALA SER THR GLU SEQRES 42 B 740 ASN ILE ILE VAL ALA SER PHE ASP GLY ARG GLY SER GLY SEQRES 43 B 740 TYR GLN GLY ASP LYS ILE MET HIS ALA ILE ASN ARG ARG SEQRES 44 B 740 LEU GLY THR PHE GLU VAL GLU ASP GLN ILE GLU ALA ALA SEQRES 45 B 740 ARG GLN PHE SER LYS MET GLY PHE VAL ASP ASN LYS ARG SEQRES 46 B 740 ILE ALA ILE TRP GLY TRP SER TYR GLY GLY TYR VAL THR SEQRES 47 B 740 SER MET VAL LEU GLY SER GLY SER GLY VAL PHE LYS CYS SEQRES 48 B 740 GLY ILE ALA VAL ALA PRO VAL SER ARG TRP GLU TYR TYR SEQRES 49 B 740 ASP SER VAL TYR THR GLU ARG TYR MET GLY LEU PRO THR SEQRES 50 B 740 PRO GLU ASP ASN LEU ASP HIS TYR ARG ASN SER THR VAL SEQRES 51 B 740 MET SER ARG ALA GLU ASN PHE LYS GLN VAL GLU TYR LEU SEQRES 52 B 740 LEU ILE HIS GLY THR ALA ASP ASP ASN VAL HIS PHE GLN SEQRES 53 B 740 GLN SER ALA GLN ILE SER LYS ALA LEU VAL ASP VAL GLY SEQRES 54 B 740 VAL ASP PHE GLN ALA MET TRP TYR THR ASP GLU ASP HIS SEQRES 55 B 740 GLY ILE ALA SER SER THR ALA HIS GLN HIS ILE TYR THR SEQRES 56 B 740 HIS MET SER HIS PHE ILE LYS GLN CYS PHE SER LEU PRO SEQRES 57 B 740 ALA ALA ALA SER TRP SER HIS PRO GLN PHE GLU LYS MODRES 4A5S ASN A 85 ASN GLYCOSYLATION SITE MODRES 4A5S ASN A 150 ASN GLYCOSYLATION SITE MODRES 4A5S ASN A 219 ASN GLYCOSYLATION SITE MODRES 4A5S ASN A 229 ASN GLYCOSYLATION SITE MODRES 4A5S ASN A 281 ASN GLYCOSYLATION SITE MODRES 4A5S ASN A 321 ASN GLYCOSYLATION SITE MODRES 4A5S ASN A 520 ASN GLYCOSYLATION SITE MODRES 4A5S ASN B 85 ASN GLYCOSYLATION SITE MODRES 4A5S ASN B 150 ASN GLYCOSYLATION SITE MODRES 4A5S ASN B 219 ASN GLYCOSYLATION SITE MODRES 4A5S ASN B 229 ASN GLYCOSYLATION SITE MODRES 4A5S ASN B 281 ASN GLYCOSYLATION SITE MODRES 4A5S ASN B 321 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET N7F A 901 37 HET NAG A1150 14 HET NAG A1219 14 HET NAG A1229 14 HET NAG A1281 14 HET NAG A1321 14 HET NAG A1520 14 HET SO4 A1767 5 HET SO4 A1768 5 HET SO4 A1769 5 HET N7F B 901 37 HET SO4 B1773 5 HET SO4 B1774 5 HET SO4 B1775 5 HET NAG B2085 14 HET NAG B2150 14 HET NAG B2219 14 HET NAG B2229 14 HET NAG B2281 14 HET NAG B2321 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM N7F 6-[(3S)-3-AMINOPIPERIDIN-1-YL]-5-BENZYL-4-OXO-3- HETNAM 2 N7F (QUINOLIN-4-YLMETHYL)-4,5-DIHYDRO-3H-PYRROLO[3,2- HETNAM 3 N7F D]PYRIMIDINE-7-CARBONITRILE HETNAM SO4 SULFATE ION FORMUL 3 NAG 14(C8 H15 N O6) FORMUL 3 MAN 3(C6 H12 O6) FORMUL 4 N7F 2(C29 H27 N7 O) FORMUL 11 SO4 6(O4 S 2-) FORMUL 24 HOH *1590(H2 O) HELIX 1 1 THR A 44 ASN A 51 1 8 HELIX 2 2 ASP A 200 VAL A 207 1 8 HELIX 3 3 PRO A 290 ILE A 295 1 6 HELIX 4 4 VAL A 341 GLN A 344 5 4 HELIX 5 5 GLU A 421 MET A 425 5 5 HELIX 6 6 ASN A 497 GLN A 505 1 9 HELIX 7 7 ASN A 562 THR A 570 1 9 HELIX 8 8 GLY A 587 HIS A 592 1 6 HELIX 9 9 ALA A 593 ASN A 595 5 3 HELIX 10 10 THR A 600 LYS A 615 1 16 HELIX 11 11 SER A 630 GLY A 641 1 12 HELIX 12 12 ARG A 658 TYR A 662 5 5 HELIX 13 13 ASP A 663 GLY A 672 1 10 HELIX 14 14 ASN A 679 SER A 686 1 8 HELIX 15 15 VAL A 688 VAL A 698 5 11 HELIX 16 16 PHE A 713 VAL A 726 1 14 HELIX 17 17 SER A 744 PHE A 763 1 20 HELIX 18 18 THR B 44 ASN B 51 1 8 HELIX 19 19 GLU B 91 GLU B 97 5 7 HELIX 20 20 ASP B 200 VAL B 207 1 8 HELIX 21 21 PRO B 290 ILE B 295 1 6 HELIX 22 22 VAL B 341 GLN B 344 5 4 HELIX 23 23 GLU B 421 MET B 425 5 5 HELIX 24 24 ASN B 497 GLN B 505 1 9 HELIX 25 25 ASN B 562 THR B 570 1 9 HELIX 26 26 GLY B 587 HIS B 592 1 6 HELIX 27 27 ALA B 593 ASN B 595 5 3 HELIX 28 28 THR B 600 MET B 616 1 17 HELIX 29 29 SER B 630 GLY B 641 1 12 HELIX 30 30 ARG B 658 TYR B 662 5 5 HELIX 31 31 ASP B 663 GLY B 672 1 10 HELIX 32 32 ASN B 679 SER B 686 1 8 HELIX 33 33 VAL B 688 VAL B 698 5 11 HELIX 34 34 HIS B 712 VAL B 726 1 15 HELIX 35 35 SER B 744 PHE B 763 1 20 SHEET 1 AA 2 LYS A 41 THR A 42 0 SHEET 2 AA 2 VAL A 507 GLN A 508 1 N GLN A 508 O LYS A 41 SHEET 1 AB 4 LEU A 60 TRP A 62 0 SHEET 2 AB 4 GLU A 67 GLN A 72 -1 O LEU A 69 N ARG A 61 SHEET 3 AB 4 ASN A 75 ASN A 80 -1 O ASN A 75 N GLN A 72 SHEET 4 AB 4 SER A 86 LEU A 90 -1 O SER A 87 N VAL A 78 SHEET 1 AC 4 ASP A 104 ILE A 107 0 SHEET 2 AC 4 PHE A 113 LYS A 122 -1 O LEU A 115 N SER A 106 SHEET 3 AC 4 TYR A 128 ASP A 136 -1 O THR A 129 N VAL A 121 SHEET 4 AC 4 GLN A 141 LEU A 142 -1 O GLN A 141 N ASP A 136 SHEET 1 AD 4 THR A 152 TRP A 157 0 SHEET 2 AD 4 LEU A 164 TRP A 168 -1 O ALA A 165 N THR A 156 SHEET 3 AD 4 ASP A 171 LYS A 175 -1 O ASP A 171 N TRP A 168 SHEET 4 AD 4 TYR A 183 ARG A 184 -1 O TYR A 183 N VAL A 174 SHEET 1 AE 2 ILE A 194 ASN A 196 0 SHEET 2 AE 2 PHE A 222 ASN A 229 -1 O PHE A 228 N TYR A 195 SHEET 1 AF 2 LEU A 214 TRP A 216 0 SHEET 2 AF 2 PHE A 222 ASN A 229 -1 O ALA A 224 N TRP A 215 SHEET 1 AG 4 SER A 284 ILE A 287 0 SHEET 2 AG 4 THR A 265 ASN A 272 -1 O PHE A 268 N ILE A 287 SHEET 3 AG 4 PHE A 222 ASN A 229 -1 O LEU A 223 N VAL A 271 SHEET 4 AG 4 LEU A 214 TRP A 216 -1 O TRP A 215 N ALA A 224 SHEET 1 AH 4 SER A 284 ILE A 287 0 SHEET 2 AH 4 THR A 265 ASN A 272 -1 O PHE A 268 N ILE A 287 SHEET 3 AH 4 PHE A 222 ASN A 229 -1 O LEU A 223 N VAL A 271 SHEET 4 AH 4 ILE A 194 ASN A 196 -1 O TYR A 195 N PHE A 228 SHEET 1 AI 2 LEU A 235 PHE A 240 0 SHEET 2 AI 2 LYS A 250 PRO A 255 -1 O LYS A 250 N PHE A 240 SHEET 1 AJ 4 HIS A 298 THR A 307 0 SHEET 2 AJ 4 ARG A 310 ARG A 317 -1 O ARG A 310 N ALA A 306 SHEET 3 AJ 4 TYR A 322 TYR A 330 -1 O TYR A 322 N ARG A 317 SHEET 4 AJ 4 TRP A 337 CYS A 339 1 O ASN A 338 N ASP A 329 SHEET 1 AK 4 HIS A 298 THR A 307 0 SHEET 2 AK 4 ARG A 310 ARG A 317 -1 O ARG A 310 N ALA A 306 SHEET 3 AK 4 TYR A 322 TYR A 330 -1 O TYR A 322 N ARG A 317 SHEET 4 AK 4 HIS A 345 MET A 348 -1 O HIS A 345 N MET A 325 SHEET 1 AL 2 TRP A 337 CYS A 339 0 SHEET 2 AL 2 TYR A 322 TYR A 330 1 O ASP A 329 N ASN A 338 SHEET 1 AM 4 HIS A 363 PHE A 364 0 SHEET 2 AM 4 SER A 370 SER A 376 -1 O TYR A 372 N HIS A 363 SHEET 3 AM 4 ARG A 382 GLN A 388 -1 O HIS A 383 N ILE A 375 SHEET 4 AM 4 THR A 395 PHE A 396 -1 O THR A 395 N TYR A 386 SHEET 1 AN 4 VAL A 404 LEU A 410 0 SHEET 2 AN 4 TYR A 414 SER A 419 -1 O TYR A 416 N GLU A 408 SHEET 3 AN 4 ASN A 430 GLN A 435 -1 O ASN A 430 N SER A 419 SHEET 4 AN 4 ASP A 438 CYS A 444 -1 N ASP A 438 O GLN A 435 SHEET 1 AO 4 TYR A 457 PHE A 461 0 SHEET 2 AO 4 TYR A 467 CYS A 472 -1 O GLN A 469 N SER A 460 SHEET 3 AO 4 LEU A 479 SER A 484 -1 O LEU A 479 N CYS A 472 SHEET 4 AO 4 LYS A 489 GLU A 495 -1 O LYS A 489 N SER A 484 SHEET 1 AP 8 SER A 511 LEU A 519 0 SHEET 2 AP 8 THR A 522 LEU A 530 -1 O THR A 522 N LEU A 519 SHEET 3 AP 8 ILE A 574 PHE A 578 -1 O VAL A 575 N ILE A 529 SHEET 4 AP 8 TYR A 540 ASP A 545 1 O PRO A 541 N ILE A 574 SHEET 5 AP 8 VAL A 619 TRP A 629 1 N ASP A 620 O TYR A 540 SHEET 6 AP 8 CYS A 649 VAL A 653 1 O CYS A 649 N ILE A 626 SHEET 7 AP 8 GLU A 699 GLY A 705 1 O GLU A 699 N GLY A 650 SHEET 8 AP 8 GLN A 731 TYR A 735 1 O GLN A 731 N LEU A 702 SHEET 1 BA 2 LYS B 41 THR B 42 0 SHEET 2 BA 2 VAL B 507 GLN B 508 1 N GLN B 508 O LYS B 41 SHEET 1 BB 4 LEU B 60 TRP B 62 0 SHEET 2 BB 4 GLU B 67 GLN B 72 -1 O LEU B 69 N ARG B 61 SHEET 3 BB 4 ASN B 75 ASN B 80 -1 O ASN B 75 N GLN B 72 SHEET 4 BB 4 SER B 86 LEU B 90 -1 O SER B 87 N VAL B 78 SHEET 1 BC 4 ASP B 104 ILE B 107 0 SHEET 2 BC 4 PHE B 113 LYS B 122 -1 O LEU B 115 N SER B 106 SHEET 3 BC 4 TYR B 128 ASP B 136 -1 O THR B 129 N VAL B 121 SHEET 4 BC 4 GLN B 141 ILE B 143 -1 O GLN B 141 N ASP B 136 SHEET 1 BD 4 TRP B 154 TRP B 157 0 SHEET 2 BD 4 LEU B 164 TRP B 168 -1 O ALA B 165 N THR B 156 SHEET 3 BD 4 ASP B 171 LYS B 175 -1 O ASP B 171 N TRP B 168 SHEET 4 BD 4 TYR B 183 ARG B 184 -1 O TYR B 183 N VAL B 174 SHEET 1 BE 2 ILE B 194 ASN B 196 0 SHEET 2 BE 2 PHE B 222 ASN B 229 -1 O PHE B 228 N TYR B 195 SHEET 1 BF 2 LEU B 214 TRP B 216 0 SHEET 2 BF 2 PHE B 222 ASN B 229 -1 O ALA B 224 N TRP B 215 SHEET 1 BG 4 ILE B 285 ILE B 287 0 SHEET 2 BG 4 THR B 265 ASN B 272 -1 O PHE B 268 N ILE B 287 SHEET 3 BG 4 PHE B 222 ASN B 229 -1 O LEU B 223 N VAL B 271 SHEET 4 BG 4 LEU B 214 TRP B 216 -1 O TRP B 215 N ALA B 224 SHEET 1 BH 4 ILE B 285 ILE B 287 0 SHEET 2 BH 4 THR B 265 ASN B 272 -1 O PHE B 268 N ILE B 287 SHEET 3 BH 4 PHE B 222 ASN B 229 -1 O LEU B 223 N VAL B 271 SHEET 4 BH 4 ILE B 194 ASN B 196 -1 O TYR B 195 N PHE B 228 SHEET 1 BI 2 LEU B 235 PHE B 240 0 SHEET 2 BI 2 LYS B 250 PRO B 255 -1 O LYS B 250 N PHE B 240 SHEET 1 BJ 4 HIS B 298 THR B 307 0 SHEET 2 BJ 4 ARG B 310 ARG B 317 -1 O ARG B 310 N ALA B 306 SHEET 3 BJ 4 TYR B 322 TYR B 330 -1 O TYR B 322 N ARG B 317 SHEET 4 BJ 4 TRP B 337 CYS B 339 1 O ASN B 338 N ASP B 329 SHEET 1 BK 4 HIS B 298 THR B 307 0 SHEET 2 BK 4 ARG B 310 ARG B 317 -1 O ARG B 310 N ALA B 306 SHEET 3 BK 4 TYR B 322 TYR B 330 -1 O TYR B 322 N ARG B 317 SHEET 4 BK 4 HIS B 345 MET B 348 -1 O HIS B 345 N MET B 325 SHEET 1 BL 2 TRP B 337 CYS B 339 0 SHEET 2 BL 2 TYR B 322 TYR B 330 1 O ASP B 329 N ASN B 338 SHEET 1 BM 4 HIS B 363 PHE B 364 0 SHEET 2 BM 4 SER B 370 SER B 376 -1 O TYR B 372 N HIS B 363 SHEET 3 BM 4 ARG B 382 GLN B 388 -1 O HIS B 383 N ILE B 375 SHEET 4 BM 4 THR B 395 PHE B 396 -1 O THR B 395 N TYR B 386 SHEET 1 BN 4 VAL B 404 LEU B 410 0 SHEET 2 BN 4 TYR B 414 SER B 419 -1 O TYR B 416 N GLU B 408 SHEET 3 BN 4 ASN B 430 GLN B 435 -1 O ASN B 430 N SER B 419 SHEET 4 BN 4 ASP B 438 CYS B 444 -1 N ASP B 438 O GLN B 435 SHEET 1 BO 4 TYR B 457 PHE B 461 0 SHEET 2 BO 4 TYR B 467 CYS B 472 -1 O GLN B 469 N SER B 460 SHEET 3 BO 4 LEU B 479 SER B 484 -1 O LEU B 479 N CYS B 472 SHEET 4 BO 4 LYS B 489 GLU B 495 -1 O LYS B 489 N SER B 484 SHEET 1 BP 8 SER B 511 LEU B 519 0 SHEET 2 BP 8 THR B 522 LEU B 530 -1 O THR B 522 N LEU B 519 SHEET 3 BP 8 ILE B 574 PHE B 578 -1 O VAL B 575 N ILE B 529 SHEET 4 BP 8 TYR B 540 ASP B 545 1 O PRO B 541 N ILE B 574 SHEET 5 BP 8 VAL B 619 TRP B 629 1 N ASP B 620 O TYR B 540 SHEET 6 BP 8 CYS B 649 VAL B 653 1 O CYS B 649 N ILE B 626 SHEET 7 BP 8 GLU B 699 GLY B 705 1 O GLU B 699 N GLY B 650 SHEET 8 BP 8 GLN B 731 TYR B 735 1 O GLN B 731 N LEU B 702 SSBOND 1 CYS A 328 CYS A 339 1555 1555 2.07 SSBOND 2 CYS A 385 CYS A 394 1555 1555 2.04 SSBOND 3 CYS A 444 CYS A 447 1555 1555 2.01 SSBOND 4 CYS A 454 CYS A 472 1555 1555 2.10 SSBOND 5 CYS A 649 CYS A 762 1555 1555 2.08 SSBOND 6 CYS B 328 CYS B 339 1555 1555 2.06 SSBOND 7 CYS B 385 CYS B 394 1555 1555 2.05 SSBOND 8 CYS B 444 CYS B 447 1555 1555 2.03 SSBOND 9 CYS B 454 CYS B 472 1555 1555 2.08 SSBOND 10 CYS B 649 CYS B 762 1555 1555 2.06 LINK ND2 ASN A 85 C1 NAG C 1 1555 1555 1.43 LINK ND2 ASN A 150 C1 NAG A1150 1555 1555 1.43 LINK ND2 ASN A 219 C1 NAG A1219 1555 1555 1.43 LINK ND2 ASN A 229 C1 NAG A1229 1555 1555 1.43 LINK ND2 ASN A 281 C1 NAG A1281 1555 1555 1.43 LINK ND2 ASN A 321 C1 NAG A1321 1555 1555 1.44 LINK ND2 ASN A 520 C1 NAG A1520 1555 1555 1.43 LINK ND2 ASN B 85 C1 NAG B2085 1555 1555 1.44 LINK ND2 ASN B 150 C1 NAG B2150 1555 1555 1.43 LINK ND2 ASN B 219 C1 NAG B2219 1555 1555 1.43 LINK ND2 ASN B 229 C1 NAG B2229 1555 1555 1.43 LINK ND2 ASN B 281 C1 NAG B2281 1555 1555 1.43 LINK ND2 ASN B 321 C1 NAG B2321 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.41 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.44 LINK O3 MAN C 3 C1 MAN C 4 1555 1555 1.42 LINK O6 MAN C 3 C1 MAN C 5 1555 1555 1.38 CISPEP 1 GLY A 474 PRO A 475 0 10.28 CISPEP 2 GLY B 474 PRO B 475 0 5.35 CRYST1 97.183 121.424 190.699 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010290 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008236 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005244 0.00000